Teva Pharmaceutical’s chief financial officer has reiterated the company has done nothing wrong in the wake of a price-fixing lawsuit filed by 44 US states.

ELAN has taken a 24% stake in US firm Proteotasis Therapeutics and said that it is likely to do another licensing deal within the next six months.

MUSSELBURGH: 1.50 Emotive; 3.20 Isla Pearl Fisher

The Financial Regulator today publishes a warning notice on Huntington Asset Management Group (Switzerland).